BioCentury
ARTICLE | Clinical News

Incivek regulatory update

October 29, 2012 7:00 AM UTC

Johnson & Johnson reached an agreement on the price for HCV drug Incivo telaprevir with Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband). The company declined to disclose th...